Analysis Report of Global Biosimilars Market 2014-2018

About This Presentation
Title:

Analysis Report of Global Biosimilars Market 2014-2018

Description:

Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market. Complete report of 106 Pages is available @ – PowerPoint PPT presentation

Number of Views:260

less

Transcript and Presenter's Notes

Title: Analysis Report of Global Biosimilars Market 2014-2018


1
Global Biosimilars Market 2014-2018
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_sandlerresearch.org with
your contact details and questions if any.
  • Published February 2014
  • Single User PDF US 3000
  • Corporate User PDF US 4000

2
Global Biosimilars Market 2014-2018
  • Global Biosimilars Market to grow at a CAGR of
    27.58 percent over the period 2013-2018. One of
    the key factors contributing to this market
    growth is the increasing number of patent
    expirations. The Global Biosimilars Market has
    also been witnessing the outsourcing of
    biosimilar manufacturing. However, the risks
    related to drug failure could pose a challenge to
    the growth of this market.
  • Global Biosimilars Market 2014-2018, has been
    prepared based on an in-depth market analysis
    with inputs from industry experts. The report
    covers Americas, EMEA and APAC regions it also
    covers the Global Biosimilars market landscape
    and its growth prospects in the coming years. The
    report also includes a discussion of the key
    vendors operating in this market.
  • Key vendors dominating this space include Biocon
    Ltd., Hospira Inc., Mylan Inc., Novartis AG, Teva
    Pharmaceutical Industries Ltd., Intas
    Pharmaceuticals Ltd., Dr. Reddys Laboratories
    Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and
    Celltrion Inc.
  • Other vendors mentioned in the report are Actavis
    plc, Amgen Inc., AstraZeneca plc, Baxter
    International Inc., Biogen Idec Inc., Bioton
    S.A., Boehringer Ingelheim GmbH, Cipla Ltd.,
    Coherus Biosciences Inc., Daiichi Sankyo Co.
    Ltd., Emcure Pharmaceuticals Ltd., GE Healthcare
    Ltd., GeneScience Pharmaceuticals Co. Ltd.,
    GlaxoSmithKline plc, JCR Pharmaceuticals Co.
    Ltd., iBio Inc., LG Life Sciences Co. Ltd., Merck
    Co. Inc., Pfizer Inc., Ranbaxy Laboratories
    Ltd., Samsung Biologics Co. Ltd., Sanofi S.A.,
    and Wockhardt Ltd.
  • Inquiry for Discount _at_ http//www.sandlerresearch.
    org/discount?rname14863

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_sandlerresearch.org with
your contact details and questions if any.
3
Global Biosimilars Market 2014-2018
  • Key questions answered in this report
  • What will the market size be in 2018 and what
    will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats
    faced by the key vendors?
  • What are the strengths and weaknesses of the key
    vendors?
  • Table Of Contents
  • 01. Executive Summary
  • 02. List of Abbreviations
  • 03. Scope of the Report
  • 04. Market Research Methodology
  • 05. Introduction
  • 06. Market Landscape

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_sandlerresearch.org with
your contact details and questions if any.
4
Global Biosimilars Market 2014-2018
  • 07. Market Segmentation by Application
  • 08. Geographical Segmentation
  • 09. Buying Criteria
  • 10. Market Growth Drivers
  • 11. Drivers and their Impact
  • 12. Market Challenges
  • 13. Impact of Drivers and Challenges
  • 14. Market Trends
  • 15. Trends and their Impact
  • 16. Vendor Landscape
  • 17. Patent Expiries
  • 18. Key Vendor Analysis
  • 19. Other Reports in this Series
  • Inquiry Before Buying on this Report
    http//www.sandlerresearch.org/inquire-before-buyi
    ng?rname14863

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_sandlerresearch.org with
your contact details and questions if any.
5
Global Biosimilars Market 2014-2018
  • List of Exhibits
  • Exhibit 1 Market Research Methodology
  • Exhibit 2 Global Biosimilars Market 2013-2018
    (US million)
  • Exhibit 3 Biosimilars Market in the US 2013-2018
    (US million)
  • Exhibit 4 Biosimilars Market in Europe 2013-2018
    (US million)
  • Exhibit 5 Biosimilars Market in Japan 2013-2018
    (US million)
  • Exhibit 6 Biosimilars Market in India 2013-2018
    (US million)
  • Exhibit 7 Biosimilars Market in China 2013-2018
    (US million)
  • Exhibit 8 Global Biosimilars Market Segmentation
    by Application
  • Exhibit 9 Global Biosimilars Market by
    Geographical Segmentation 2013
  • Exhibit 10 Biosimilars Market in the APAC Region
    2013-2018 (US million)
  • Exhibit 11 Biosimilars Market in the EMEA Region
    2013-2018 (US million)
  • Exhibit 12 Biosimilars Market in the Americas
    2013-2018 (US million)
  • Complete report of 106 Pages is available
    _at_http//www.sandlerresearch.org/global-biosimilars
    -market-2014-2018.html
  • Browse more report on Pharmaceutical

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_sandlerresearch.org with
your contact details and questions if any.
Write a Comment
User Comments (0)